Prior to surgery, it is very difficult today to determine if rectal cancer has spread to the lymph nodes. The spread is not verified until the surgical preparate has been examined microscopally.
The five-year survival rate for persons suffering from rectal cancer is currently no more than 67 percent. Our system aims to fill the void in the current care, and we have thus developed a novel medical imaging method based on magnetomotive ultrasound.
Among other things, we want to enable more patients to get minimally invasive surgical procedure instead of extensive, unnecessary and risky surgery.
Our innovation comprises the combination of nanotechnology with modern ultrasound technology. We combine a magnetic field with diagnostic ultrasound in an entirely new way. As such, we can bring the inherently cost-efficient ultrasound technology into completely new application areas. Our primary focus is on rectal cancer and the mapping of cancer spread to nearby lymph nodes. The spread of cancer to nearby lymph nodes is an important marker for the cancer’s progression. It is also essential to be able to design a personalized treatment.
The stand-alone, portable system comprises a hand-held probe, an ultrasound scanner and a software that controls the system and generates the imaging signal, which we call NanoTrace®.
Development is conducted together with reputable development companies, in well-defined stages with clear deliverables. This optimizes the possibility of efficiently developing a commercial product for the market.